Northwest Investment Counselors’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,013
| Closed | -$41.5K | – | 588 |
|
|
2022
Q4 | $41.5K | Buy |
1,013
+5
| +0.5% | +$205 | 0.01% | 260 |
|
|
2022
Q3 | $40K | Buy |
1,008
+3
| +0.3% | +$119 | 0.01% | 238 |
|
|
2022
Q2 | $42K | Buy |
1,005
+4
| +0.4% | +$167 | 0.01% | 233 |
|
|
2022
Q1 | $45K | Buy |
1,001
+4
| +0.4% | +$180 | 0.01% | 241 |
|
|
2021
Q4 | $46K | Buy |
+997
| New | +$46K | 0.01% | 238 |
|
|
2021
Q2 | – | Sell |
-990
| Closed | -$50K | – | 461 |
|
|
2021
Q1 | $50K | Buy |
+990
| New | +$50K | 0.01% | 219 |
|
|
2017
Q4 | – | Sell |
-1,156
| Closed | -$49K | – | 319 |
|
|
2017
Q3 | $49K | Buy |
+1,156
| New | +$49K | 0.02% | 182 |
|